248 related articles for article (PubMed ID: 12439171)
21. 18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT).
Lassen U; Daugaard G; Eigtved A; Damgaard K; Friberg L
Eur J Cancer; 1999 Jul; 35(7):1076-82. PubMed ID: 10533451
[TBL] [Abstract][Full Text] [Related]
22. Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown primary in the head and neck.
Kothari P; Randhawa PS; Farrell R
Br J Oral Maxillofac Surg; 2008 Jun; 46(4):283-7. PubMed ID: 18243447
[TBL] [Abstract][Full Text] [Related]
23. Positron emission imaging of head and neck cancer, including thyroid carcinoma.
Schöder H; Yeung HW
Semin Nucl Med; 2004 Jul; 34(3):180-97. PubMed ID: 15202100
[TBL] [Abstract][Full Text] [Related]
24. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Paul SA; Stoeckli SJ; von Schulthess GK; Goerres GW
Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):189-95. PubMed ID: 17177026
[TBL] [Abstract][Full Text] [Related]
25. Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
Schechter NR; Gillenwater AM; Byers RM; Garden AS; Morrison WH; Nguyen LN; Podoloff DA; Ang KK
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):4-9. PubMed ID: 11516844
[TBL] [Abstract][Full Text] [Related]
26. The role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site.
Sève P; Billotey C; Broussolle C; Dumontet C; Mackey JR
Cancer; 2007 Jan; 109(2):292-9. PubMed ID: 17167760
[TBL] [Abstract][Full Text] [Related]
27. The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer.
Kutler DI; Wong RJ; Schoder H; Kraus DH
Curr Opin Otolaryngol Head Neck Surg; 2006 Apr; 14(2):73-81. PubMed ID: 16552262
[TBL] [Abstract][Full Text] [Related]
28. The role of positron emission tomography in occult primary head and neck cancers.
Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
[TBL] [Abstract][Full Text] [Related]
29. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
[TBL] [Abstract][Full Text] [Related]
30. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
31. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
32. The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Oral Oncol; 1999 Jul; 35(4):390-4. PubMed ID: 10645404
[TBL] [Abstract][Full Text] [Related]
33. The impact of FDG PET on the management of occult primary head and neck tumours.
Wong WL; Saunders M
Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
[TBL] [Abstract][Full Text] [Related]
34. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
35. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor.
Rusthoven KE; Koshy M; Paulino AC
Cancer; 2004 Dec; 101(11):2641-9. PubMed ID: 15517576
[TBL] [Abstract][Full Text] [Related]
36. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
[TBL] [Abstract][Full Text] [Related]
37. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
[TBL] [Abstract][Full Text] [Related]
38. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
Jereczek-Fossa BA; Jassem J; Orecchia R
Cancer Treat Rev; 2004 Apr; 30(2):153-64. PubMed ID: 15023433
[TBL] [Abstract][Full Text] [Related]
39. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
40. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]